Neurogene (NGNE) Tax Rate (2013 - 2014)
Neurogene (NGNE) reported Tax Rate of 0.0% for Q3 2014, down 15.0% on a YoY basis from 0.0% in Q3 2013, and up 384.2% quarter-over-quarter from 0.0% in Q4 2013.
Neurogene (NGNE) Tax Rate (2013 - 2014) Analysis & Trends
Neurogene has reported Tax Rate for 2 years, with the latest figure at 0.0% in Q3 2014.
- For the quarter ending Q3 2014, Tax Rate fell 15.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2014 stood at 0.02% (changed N/A YoY), and the FY2014 full-year result was 0.0%, down 6.0% from the prior year.
- Tax Rate for Q3 2014 stood at 0.0%, up from 0.0% in the prior quarter.
- The five-year high for Tax Rate was 0.15% in Q3 2013, with the low at 0.0% in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Neurogene | 216.17 Mn | 216.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 0.00% |
| Sep 30, 2014 | 0.00% |
| Dec 31, 2013 | 0.00% |
| Dec 31, 2013 | 0.00% |
| Sep 30, 2013 | 0.15% |
| Sep 30, 2013 | 0.15% |